Goff Brian
- SEC CIK
- 0001546216
In the past year, 3 open-market sale filings worth $1.69M and no purchases.
Current role at each company
- AGIO Agios Pharmaceuticals, Inc.Chief Executive Officeras of Jun 23, 2026
- NTLA Intellia Therapeutics, Inc.Directoras of Jun 10, 2026
- ALXN Alexion Pharmaceuticals, Inc.EVP & Chief Commercial Officeras of Jul 23, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.69M
- 3 filings
- Net
- −$1.69M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Goff Brian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AGIO Agios Pharmaceuticals, Inc.
Chief Executive Officer13 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 (view filing) | Jun 30 | Same day | Goff BrianChief Executive Officer | SSale | −11.4K | $28.36 | −$324.7K | −44.8%14.1K after | 10b5-1 |
| Aug 10, 2023 (view filing) | Aug 8 | 2 days | Goff BrianChief Executive Officer | SSale | −10.2K | $25.48 | −$259.3K | −27.7%26.6K after | 10b5-1 |
| Jan 9, 2024 (view filing) | Jan 9 | Same day | Goff BrianChief Executive Officer | SSale | −12.1K | $22.99 | −$277.4K | −23.2%40.1K after | 10b5-1 |
| Jan 24, 2024 (view filing) | Jan 24 | Same day | Goff BrianChief Executive Officer | SSale | −7.63K | $21.64 | −$165.2K | −13.4%49.4K after | 10b5-1 |
| Mar 5, 2024 (view filing) | Mar 5 | Same day | Goff BrianChief Executive Officer | SSale | −4.16K | $32.57 | −$135.4K | −7.2%53.8K after | 10b5-1 |
| Jun 7, 2024 (view filing) | Jun 5 | 2 days | Goff BrianChief Executive Officer | SSale | −12.1K | $48.84 | −$591.7K | −15.3%67.2K after | 10b5-1 |
| Aug 12, 2024 (view filing) | Aug 8 | 4 days | Goff BrianChief Executive Officer | SSale | −11.1K | $42.75 | −$474.1K | −12.3%78.8K after | 10b5-1 |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Goff BrianChief Executive Officer | SSale | −12.9K | $35.54 | −$460.1K | −12.3%92.3K after | 2 lots10b5-1 |
| Jun 26, 2025 (view filing) | Jun 24 | 2 days | Goff BrianChief Executive Officer | SSale | −18.7K | $33.54 | −$627.2K | −14.3%111.9K after | 2 lots10b5-1 |
| Aug 12, 2025 (view filing) | Aug 8 | 4 days | Goff BrianChief Executive Officer | SSale | −11.1K | $36.67 | −$406.5K | −8.2%123.5K after | 10b5-1 |